Your browser is no longer supported. Please, upgrade your browser.
Settings
TENX [NASD]
Tenax Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.20 Insider Own0.33% Shs Outstand12.43M Perf Week1.14%
Market Cap22.25M Forward P/E- EPS next Y-0.20 Insider Trans- Shs Float10.56M Perf Month67.92%
Income-9.80M PEG- EPS next Q-0.14 Inst Own32.20% Short Float0.28% Perf Quarter32.84%
Sales- P/S- EPS this Y85.00% Inst Trans- Short Ratio0.01 Perf Half Y47.11%
Book/sh0.60 P/B2.97 EPS next Y77.30% ROA-147.20% Target Price- Perf Year36.92%
Cash/sh0.70 P/C2.56 EPS next 5Y- ROE-222.70% 52W Range0.25 - 2.84 Perf YTD-4.30%
Dividend- P/FCF- EPS past 5Y33.00% ROI- 52W High-37.32% Beta2.44
Dividend %- Quick Ratio6.50 Sales past 5Y- Gross Margin- 52W Low612.00% ATR0.17
Employees9 Current Ratio6.50 Sales Q/Q- Oper. Margin- RSI (14)64.56 Volatility6.18% 10.27%
OptionableNo Debt/Eq0.03 EPS Q/Q45.80% Profit Margin- Rel Volume0.08 Prev Close1.78
ShortableYes LT Debt/Eq0.03 Earnings- Payout- Avg Volume4.10M Price1.78
Recom1.50 SMA2016.76% SMA5043.98% SMA20052.84% Volume347,307 Change0.00%
May-18-17Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14Initiated MLV & Co Buy $7
Nov-18-14Initiated WallachBeth Buy $12
Dec-29-20 04:29PM  
10:12AM  
Dec-03-20 07:47AM  
Nov-29-20 07:28PM  
Nov-16-20 04:45PM  
Nov-10-20 08:30AM  
Nov-06-20 08:30AM  
Oct-15-20 08:30AM  
Oct-02-20 08:30AM  
Sep-01-20 10:44AM  
Aug-31-20 08:30AM  
Aug-28-20 10:54AM  
Aug-17-20 08:00AM  
Jul-20-20 08:45AM  
Jul-06-20 07:50PM  
Jun-03-20 09:41AM  
08:30AM  
Jun-02-20 07:30AM  
Jun-01-20 05:30AM  
May-29-20 01:07PM  
Apr-13-20 05:55AM  
05:40AM  
Apr-09-20 08:30AM  
Mar-19-20 10:16AM  
Mar-12-20 08:30AM  
08:00AM  
Feb-21-20 08:30AM  
Jan-21-20 06:15AM  
Jan-13-20 08:30AM  
Dec-20-19 12:03PM  
Nov-04-19 10:45AM  
Oct-31-19 08:00AM  
Sep-20-19 03:11PM  
Sep-12-19 09:15AM  
Aug-29-19 08:00AM  
Aug-23-19 08:00AM  
Jul-16-19 12:23PM  
Jun-12-19 11:25AM  
Apr-11-19 10:15AM  
Mar-11-19 03:20PM  
08:30AM  
Feb-21-19 01:35PM  
Feb-04-19 08:30AM  
Jan-04-19 08:30AM  
Dec-11-18 04:00PM  
Dec-07-18 01:02PM  
Nov-26-18 11:00AM  
Nov-21-18 03:21PM  
Nov-19-18 08:00AM  
Nov-07-18 04:20PM  
Oct-01-18 09:04AM  
Sep-20-18 08:30AM  
Sep-04-18 10:45AM  
Aug-29-18 08:30AM  
Aug-28-18 08:30AM  
Jun-11-18 07:24PM  
Jun-07-18 09:30AM  
Jun-05-18 04:30PM  
Jun-04-18 08:37AM  
Jun-01-18 08:30AM  
May-24-18 02:27PM  
Apr-13-18 12:55PM  
Apr-12-18 10:10AM  
Apr-06-18 01:36PM  
08:21AM  
Apr-05-18 02:43PM  
08:05AM  
Apr-04-18 10:23AM  
08:00AM  
Mar-14-18 08:00AM  
Mar-08-18 02:11PM  
Mar-02-18 08:10AM  
Mar-01-18 08:30AM  
Feb-23-18 08:00AM  
Feb-06-18 08:30AM  
Jan-16-18 07:45AM  
Jan-02-18 08:09PM  
Aug-02-17 07:00AM  
Jul-28-17 05:00PM  
May-16-17 04:33PM  
Apr-10-17 03:25PM  
Apr-05-17 05:30PM  
Mar-27-17 09:00AM  
Mar-22-17 01:04PM  
Mar-21-17 07:07AM  
06:00AM  
Mar-20-17 04:05PM  
Mar-17-17 05:02PM  
Mar-16-17 04:34PM  
Mar-15-17 04:31PM  
Feb-08-17 04:50PM  
Jan-31-17 04:04PM  
09:00AM  
Jan-30-17 09:45AM  
Jan-27-17 09:07AM  
Jan-10-17 08:05AM  
Dec-16-16 06:15AM  
Nov-21-16 11:15AM  
Nov-18-16 08:30AM  
Nov-10-16 07:07AM  
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing low cardiac output syndrome. It is also involved in initiating a Phase 2 clinical trial of levosimendan for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARMISTICE CAPITAL, LLCDirectorSep 08Buy1.468,54312,4732,019,995Sep 09 07:04 PM
ARMISTICE CAPITAL, LLCDirectorSep 04Buy1.4123,45733,0742,011,452Sep 09 07:04 PM
ARMISTICE CAPITAL, LLCDirectorSep 03Buy1.3936,00050,0401,987,995Sep 03 05:39 PM
ARMISTICE CAPITAL, LLCDirectorSep 02Buy1.4720,00029,4001,951,995Sep 03 05:39 PM
ARMISTICE CAPITAL, LLCDirectorSep 01Buy1.4630,00043,8001,931,995Sep 03 05:39 PM
ARMISTICE CAPITAL, LLCDirectorAug 31Buy1.4520,00029,0001,901,995Aug 31 07:38 PM
ARMISTICE CAPITAL, LLCDirectorAug 27Buy1.5012,00018,0001,881,995Aug 31 07:38 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 26Buy1.5012,00018,0001,869,995Aug 26 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 25Buy1.5317,21126,3331,857,995Aug 26 05:47 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 24Buy1.475,6928,3671,840,784Aug 26 05:47 PM
ARMISTICE CAPITAL, LLCDirectorAug 21Buy1.44116,242167,3881,835,092Aug 21 05:56 PM
ARMISTICE CAPITAL, LLCDirectorAug 20Buy1.53124,472190,4421,718,850Aug 21 05:56 PM
ARMISTICE CAPITAL, LLCDirectorAug 19Buy1.4570,767102,6121,594,378Aug 21 05:56 PM
BLANCK RONALD RDirectorMay 18Buy0.955,0004,7746,062May 19 04:31 PM